New nonprofit Phage One Voice says it aims to raise public awareness of phage therapy, support access pathways for patients with bacterial infections that do not respond to antibiotics, and build a ...

It is a great pleasure to announce that Professor Robert T. Schooley, from the University of California, San Diego (USA), will be a keynote speaker at the 8th World Congress on Targeting Phage Therapy ...

Antimicrobial resistance, in which germs like bacteria and fungi no longer respond to medicines, is a rising global threat. When antibiotics and other drugs become ineffective, infections can become ...

There’s nothing retro about retrons, which are bacterial molecules that produce DNA. Although retrons ordinarily serve an immune function in bacteria, they can, upon modification, acquire a genetic ...

During IDWeek 2025 in Atlanta, Georgia, Loren G. Miller, MD, MPH, investigator at The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, presented findings from the Phase IIa ...

Join clinicians, scientists, regulators, and industry leaders for two days focused on turning phage therapy into clinical reality — from GMP production and regulatory harmonization to precision ...

As the number of antibiotic-resistant infections continues to rise, scientists are looking to bacteriophages (“phages”), viruses that infect bacteria, as an approach to tackling antibiotic resistance.

Peering through his microscope in 1910, Franco-Canadian microbiologist Félix d'Hérelle noticed some "clear spots" in his bacterial cultures, an anomaly that turned out to be viruses preying on the ...

Viruses of bacteria, known as bacteriophages or phages, were discovered nearly 100 years ago. Their potential as antibacterial agents was appreciated almost immediately, with the first 'phage therapy' ...

It is not only antibiotics but also certain viruses—known as bacteriophages—that can kill off pathogenic bacteria. However, Switzerland lacks the legal framework for the use of these viruses in ...